Evidence map›Paper›PMID 32770034›Full record

ArticleScientific reports2020

Rock inhibition promotes Na

Lucile Poisson, Osbaldo Lopez-Charcas, Stéphanie Chadet, Emeline Bon, Roxane Lemoine, Lucie Brisson, Mehdi Ouaissi, Christophe Baron, Pierre Besson, Sébastien Roger and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Ion Transporting Proteins and Cancer: Progress and Perspectives.Reviews of physiology, biochemistry and pharmacology · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Lucile Poisson *EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Osbaldo Lopez-Charcas *EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.ORCID http://orcid.org/0000-0002-5080-8310
Stéphanie ChadetEA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Emeline BonEA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Roxane LemoineEA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Lucie BrissonInserm UMR1069, Nutrition, Croissance et Cancer, Université de Tours, Tours, France.ORCID http://orcid.org/0000-0001-7811-1382
Mehdi OuaissiEA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Christophe BaronEA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Pierre Besson *EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Sébastien Roger *EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France. sebastien.roger@univ-tours.fr.ORCID http://orcid.org/0000-0002-9852-5248
Driffa Moussata *EA4245 Transplantation, Immunologie, Inflammation, Université de Tours, 10 Boulevard Tonnellé, 37032, Tours, France.
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The acquisition of invasive capacities by carcinoma cells, i.e. their ability to migrate through and to remodel extracellular matrices, is a determinant process leading to their dissemination and to the development of metastases. these cancer cell properties have often been associated with an increased Rho-ROCK signalling, and ROCK inhibitors have been proposed for anticancer therapies. In this study we used the selective ROCK inhibitor, Y-27632, to address the participation of the Rho-ROCK signalling pathway in the invasive properties of SW620 human colon cancer cells. Contrarily to initial assumptions, Y-27632 induced the acquisition of a pro-migratory cell phenotype and increased cancer cell invasiveness in both 3- and 2-dimensions assays. This effect was also obtained using the other ROCK inhibitor Fasudil as well as with knocking down the expression of ROCK-1 or ROCK-2, but was prevented by the inhibition of Na

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAmidesCell Line, TumorCell MovementColonic NeoplasmsHumansNAV1.5 Voltage-Gated Sodium ChannelNeoplasm InvasivenessProtein Serine-Threonine KinasesPyridinesSignal Transduction1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAmidesfasudilNAV1.5 Voltage-Gated Sodium ChannelProtein Serine-Threonine KinasesPyridinesY 27632

Identifiers

PMID32770034
PMCPMC7414216
OpenAlexW3048175359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.